LUM/IVA

Idiopathic Pulmonary Fibrosis

Clinical trials

Developer

Vertex Pharmaceuticals Incorporated

Overview

LUM/IVA is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 7 tracked IPF clinical trials.

LUM/IVA clinical trials

NCT02875366 (Phase 4)NCT02797132 (Phase 3)NCT03125395 (Phase 3)NCT03061331 (Phase 2)NCT04235140 (Phase 3)NCT02544451 (Phase 3)NCT03625466 (Phase 2)

Explore related

All trials Research

Medical disclaimer. This page summarizes research about LUM/IVA for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.